Onderneming Alterity Therapeutics Ltd Australian S.E.
Aandelen
AU000000PBT9
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 01-05-17 |
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 01-05-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 11-11-97 |
Peter Marks
BRD | Director/Board Member | 68 | 29-07-05 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 08-08-11 |
Brian Meltzer
BRD | Director/Board Member | 70 | 09-12-99 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 802 360 380 | 2 436 015 074 ( 86,93 %) | 0 | 86,93 % |
Bedrijfsgegevens
Alterity Therapeutics Ltd.
350 Collins Street Level 14
3000, Melbourne
+61 3 9349 4906
http://www.alteritytherapeutics.com![Adres Alterity Therapeutics Ltd](https://cdn.zonebourse.com/static/address/10352933.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,72% | 44,87 mld. | |
-10,33% | 37,8 mld. | |
+37,55% | 37,61 mld. | |
+29,36% | 31,32 mld. | |
-8,44% | 27,4 mld. | |
+12,45% | 26,32 mld. | |
+44,19% | 14,07 mld. | |
+31,93% | 12,5 mld. | |
-7,67% | 11,23 mld. |